Clinical Trials Logo

Thyroiditis, Autoimmune clinical trials

View clinical trials related to Thyroiditis, Autoimmune.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT03103776 Active, not recruiting - Clinical trials for Thyroiditis, Autoimmune

Involvement of Polyomaviruses in the Pathogenesis of Autoimmune Thyroiditis and Goitrigenesis.

IPoTAIG
Start date: March 22, 2016
Phase: N/A
Study type: Interventional

Autoimmune thyroiditis and goitres are frequent pathologies.

NCT ID: NCT02302768 Active, not recruiting - Clinical trials for Thyroiditis Autoimmune

Effect of Semet (80 and 160 mcg) Versus Placebo in Euthyroid Patients With AIT

Start date: December 2012
Phase: Phase 2
Study type: Interventional

Over the past 10 years, several clinical studies have suggested that selenium supplementation may influence the natural history of AIT. Recently, Interferon gamma (IFNγ)-inducible chemokines (CXCL-9, -10 and -11) were shown to be elevated in the AIT patients. The aim of this prospective, randomized, controlled study is to evaluate the effect of two different doses of selenomethionine (80 or 160 mcg) versus placebo in euthyroid women with AIT, in terms of reduction of anti-thyroid antibodies and improvement of thyroid hypoechogenicity, over 24 months. Serum levels of selenium, CXCL-9, -10 and -11 and their regulators, Tumor necrosis factor alpha (TNFα) and INFγ, thyroid function and volume and the quality of life of AIT patients are also evaluated.